Page last updated: 2024-10-31

2,7-diaminomitosene and Adenocarcinoma

2,7-diaminomitosene has been researched along with Adenocarcinoma in 1 studies

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research Excerpts

ExcerptRelevanceReference
"Pharmacokinetics and metabolism of mitomycin C (MMC) have been studied in NMRI mice bearing MAC 16 colon adenocarcinoma after direct intratumoural injection of either 500 micrograms free MMC or the same dose incorporated in albumin microspheres."3.69Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity. Implications for the drugs' in vivo mechanism of action. ( Allan, L; Cummings, J; Smyth, JF, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cummings, J1
Allan, L1
Smyth, JF1

Other Studies

1 other study available for 2,7-diaminomitosene and Adenocarcinoma

ArticleYear
Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity. Implications for the drugs' in vivo mechanism of action.
    Biochemical pharmacology, 1994, Apr-20, Volume: 47, Issue:8

    Topics: Adenocarcinoma; Albumins; Animals; Antineoplastic Agents; Biotransformation; Colonic Neoplasms; Drug

1994